Skip to main content
. 2020 Oct 16;12(10):3000. doi: 10.3390/cancers12103000

Table 1.

Demographic, clinical and lifestyle characteristics of participants according to current cognitive complaints.

N (%) All Sample Participants with Current Cognitive Complaints (n = 657) Participants without Current Cognitive Complaints (n = 736) p
Age in years
21–44 322 (23.1%) 226 (34.4%) 96 (13.0%) <0.001
45–64 940 (67.5%) 413 (62.9%) 527 (71.6%)
≥65 131 (9.4%) 18 (2.7%) 113 (15.4%)
Education level
Low 44 (3.2%) 17 (2.6%) 27 (3.7%) 0.284
Middle 373 (26.8%) 168 (25.6%) 205 (27.8%)
High 976 (70.0%) 472 (71.8%) 504 (68.5%)
Employment
Full-time or part-time 787 (56.5%) 384 (58.5%) 403 (54.8%) <0.001
Sick leave 148 (10.6%) 100 (15.2%) 48 (6.5%)
Student, retired 249 (17.9%) 58 (8.8%) 191 (25.9%)
Unemployed 64 (4.6%) 39 (5.9%) 25 (3.4%)
Other 145 (10.4%) 76 (11.6%) 69 (9.4%)
Married/partnered
No 364 (26.1%) 159 (24.2%) 205 (27.9%) 0.121
Yes 1029 (73.9%) 498 (75.8%) 531 (72.1%)
Cancer without metastasis
Yes 1236 (88.7%) 575 (87.5%) 661 (89.8%) 0.177
No 157 (11.3%) 82 (12.5%) 75 (10.2%)
Post-cancer curative treatment time
≤1 year 373 (26.8%) 210 (32.0%) 163 (22.1%) <0.001
1–3 years 336 (24.1%) 167 (25.4%) 169 (23.0%)
≥3 years 684 (49.1%) 280 (42.6%) 404 (54.9%)
BMI
Insufficient 51 (3.7%) 30 (4.6%) 21 (2.9%) 0.037
Normal 802 (57.6%) 377 (57.4%) 425 (57.7%)
Overweight 377 (27.0%) 162 (24.6%) 215 (29.2%)
Obesity 163 (11.7%) 88 (13.4%) 75 (10.2%)
Frequency of psychotropic treatments
Never 914 (65.6%) 389 (59.2%) 525 (71.3%) <0.001
<1/month 169 (12.1%) 91 (13.8%) 78 (10.6%)
>1/month and <1/week 77 (5.5%) 38 (5.8%) 39 (5.3%)
>1/week 233 (16.8%) 139 (21.2%) 94 (12.8%)
Self-reported sleep difficulties
Never 95 (6.8%) 34 (5.2%) 61 (8.3%) <0.001
Sometimes 481 (34.5%) 197 (30.0%) 284 (38.6%)
Often 817 (58.7%) 426 (64.8%) 391 (53.1%)
Physical activity
None or < once a week 446 (32.0%) 203 (30.9%) 243 (33.0%) 0.431
Once a week 255 (18.3%) 116 (17.7%) 139 (18.9%)
Twice a week 362 (26.0%) 184 (28.0%) 178 (24.2%)
≥3 times a week 330 (23.7%) 154 (23.4%) 176 (23.9%)
History of neurological disease
No 1316 (94.5%) 625 (95.1%) 691 (93.9%) 0.311
Yes 77 (5.5%) 32 (4.9%) 45 (6.1%)
Pre-existing knowledge 1
No 842 (60.5%) 359 (54.6%) 483 (65.6%) <0.001
Yes 551 (39.5%) 298 (45.4%) 253 (34.4%)

1 Pre-existing knowledge about chemotherapy-associated cognitive problems. In bold in the table: significant results.